ENLV (Enlivex) Total Operating Expense: $15.00 Mil (TTM As of Dec. 2025)


ENLV Enlivex Ltd ENLV
31 GF Score
Price $6.86
! 2 Warning Signs
View Full Analysis

What is Enlivex Total Operating Expense?

Enlivex ENLV -7.30% 31 Total Operating Expense is $15.00 Mil as of Dec. 2025. GuruFocus rates ENLV with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

Enlivex's Total Operating Expense for the three months ended in Dec. 2025 was $5.86 Mil. Enlivex's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $15.00 Mil.

Enlivex Total Operating Expense Related Terms

Enlivex Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Enlivex's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enlivex Total Operating Expense Chart

Enlivex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.29 25.80 25.15 14.93 15.00

Enlivex Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.88 3.50 3.08 2.56 5.86
ENLV
31GF Score
Enlivex Ltd ENLV
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enlivex Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $15.00 Mil mean?
Enlivex (ENLV) has a Total Operating Expense of $15.00 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Enlivex and its competitors.
Is Enlivex's Total Operating Expense too high?
Enlivex's current Total Operating Expense is $15.00 Mil. Overall, Enlivex has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Enlivex's Total Operating Expense compare to CNTB and SMNR?
Enlivex's Total Operating Expense of $15.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Enlivex and its competitors. Enlivex's current Total Operating Expense is $15.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enlivex stock overvalued right now?
Enlivex (ENLV) has a current Total Operating Expense of $15.00 Mil. The current Total Operating Expense is $15.00 Mil. Enlivex's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Enlivex (ENLV), the current Total Operating Expense is $15.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enlivex Business Description

Other Exchanges 1BT:Germany
Address 14 Einstein Street, Weizmann Science Park, Ness Ziona, ISR, 7403618
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
31GF Score

Get the complete analysis for ENLV

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.86
Price